Phospho-YY1 (Ser365) Antibody - #AF3694
Product: | Phospho-YY1 (Ser365) Antibody |
Catalog: | AF3694 |
Description: | Rabbit polyclonal antibody to Phospho-YY1 (Ser365) |
Application: | WB IHC IF/ICC |
Reactivity: | Human, Mouse, Rat |
Mol.Wt.: | 45kD(Calculated). |
Uniprot: | P25490 |
RRID: | AB_2847008 |
Product Info
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Cite Format: Affinity Biosciences Cat# AF3694, RRID:AB_2847008.
Fold/Unfold
CF1; Delta; Delta transcription factor; INO80 complex subunit S; INO80S; NF E1; NF-E1; NFE1; OTTHUMP00000197459; Transcriptional repressor protein YY1; TYY1_HUMAN; UCR motif DNA binding protein; UCRBP; Yin and yang 1; Yin and Yang 1 protein; Yin Yang 1; Ying Yang 1; YY 1; YY 1 transcription factor; YY-1; YY1; YY1 transcription factor;
Immunogens
A synthesized peptide derived from human YY1 around the phosphorylation site of Ser365.
- P25490 TYY1_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MASGDTLYIATDGSEMPAEIVELHEIEVETIPVETIETTVVGEEEEEDDDDEDGGGGDHGGGGGHGHAGHHHHHHHHHHHPPMIALQPLVTDDPTQVHHHQEVILVQTREEVVGGDDSDGLRAEDGFEDQILIPVPAPAGGDDDYIEQTLVTVAAAGKSGGGGSSSSGGGRVKKGGGKKSGKKSYLSGGAGAAGGGGADPGNKKWEQKQVQIKTLEGEFSVTMWSSDEKKDIDHETVVEEQIIGENSPPDYSEYMTGKKLPPGGIPGIDLSDPKQLAEFARMKPRKIKEDDAPRTIACPHKGCTKMFRDNSAMRKHLHTHGPRVHVCAECGKAFVESSKLKRHQLVHTGEKPFQCTFEGCGKRFSLDFNLRTHVRIHTGDRPYVCPFDGCNKKFAQSTNLKSHILTHAKAKNNQ
PTMs - P25490 As Substrate
Site | PTM Type | Enzyme | Source |
---|---|---|---|
Y8 | Phosphorylation | P07948 (LYN) | Uniprot |
T39 | Phosphorylation | P53350 (PLK1) | Uniprot |
S118 | Phosphorylation | P68400 (CSNK2A1) | Uniprot |
S165 | Phosphorylation | Uniprot | |
K173 | Ubiquitination | Uniprot | |
K174 | Acetylation | Uniprot | |
S180 | Phosphorylation | Q96GD4 (AURKB) | Uniprot |
K183 | Methylation | Uniprot | |
K183 | Sumoylation | Uniprot | |
K183 | Ubiquitination | Uniprot | |
S184 | Phosphorylation | Q96GD4 (AURKB) | Uniprot |
Y185 | Phosphorylation | Uniprot | |
S187 | Phosphorylation | Uniprot | |
K203 | Acetylation | Uniprot | |
K203 | Sumoylation | Uniprot | |
K203 | Ubiquitination | Uniprot | |
K204 | Acetylation | Uniprot | |
K208 | Ubiquitination | Uniprot | |
S225 | Phosphorylation | Uniprot | |
S226 | Phosphorylation | Uniprot | |
S247 | Phosphorylation | Uniprot | |
Y251 | Phosphorylation | Uniprot | |
Y254 | Phosphorylation | P07948 (LYN) | Uniprot |
K258 | Acetylation | Uniprot | |
K258 | Ubiquitination | Uniprot | |
K274 | Ubiquitination | Uniprot | |
K286 | Sumoylation | Uniprot | |
K288 | Sumoylation | Uniprot | |
K288 | Ubiquitination | Uniprot | |
K301 | Methylation | Uniprot | |
K301 | Ubiquitination | Uniprot | |
K305 | Methylation | Uniprot | |
K305 | Ubiquitination | Uniprot | |
R308 | Methylation | Uniprot | |
S311 | Phosphorylation | Uniprot | |
K315 | Methylation | Uniprot | |
K315 | Ubiquitination | Uniprot | |
K332 | Ubiquitination | Uniprot | |
K339 | Acetylation | Uniprot | |
K339 | Sumoylation | Uniprot | |
K339 | Ubiquitination | Uniprot | |
T348 | Phosphorylation | Uniprot | |
K351 | Acetylation | Uniprot | |
K351 | Sumoylation | Uniprot | |
K351 | Ubiquitination | Uniprot | |
K362 | Methylation | Uniprot | |
S365 | Phosphorylation | Uniprot | |
T378 | Phosphorylation | Uniprot | |
R381 | Methylation | Uniprot | |
Y383 | Phosphorylation | P07948 (LYN) | Uniprot |
K393 | Sumoylation | Uniprot | |
K393 | Ubiquitination | Uniprot | |
K401 | Sumoylation | Uniprot | |
K401 | Ubiquitination | Uniprot | |
K409 | Ubiquitination | Uniprot |
Research Backgrounds
Multifunctional transcription factor that exhibits positive and negative control on a large number of cellular and viral genes by binding to sites overlapping the transcription start site. Binds to the consensus sequence 5'-CCGCCATNTT-3'; some genes have been shown to contain a longer binding motif allowing enhanced binding; the initial CG dinucleotide can be methylated greatly reducing the binding affinity. The effect on transcription regulation is depending upon the context in which it binds and diverse mechanisms of action include direct activation or repression, indirect activation or repression via cofactor recruitment, or activation or repression by disruption of binding sites or conformational DNA changes. Its activity is regulated by transcription factors and cytoplasmic proteins that have been shown to abrogate or completely inhibit YY1-mediated activation or repression. For example, it acts as a repressor in absence of adenovirus E1A protein but as an activator in its presence. Acts synergistically with the SMAD1 and SMAD4 in bone morphogenetic protein (BMP)-mediated cardiac-specific gene expression. Binds to SMAD binding elements (SBEs) (5'-GTCT/AGAC-3') within BMP response element (BMPRE) of cardiac activating regions. May play an important role in development and differentiation. Proposed to recruit the PRC2/EED-EZH2 complex to target genes that are transcriptional repressed. Involved in DNA repair. In vitro, binds to DNA recombination intermediate structures (Holliday junctions). Plays a role in regulating enhancer activation.
Proposed core component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair; proposed to target the INO80 complex to YY1-responsive elements.
Transiently poly-ADP-ribosylated by PARP1 upon DNA damage, with the effect of decreasing affinity of YY1 to its cognate DNA binding sites.
Ubiquitinated.
Nucleus matrix.
Note: Associated with the nuclear matrix.
Interacts with YAF2 through the region encompassing the first and second zinc fingers. Component of the chromatin remodeling INO80 complex; specifically part of a complex module associated with the DBINO domain of INO80. Interacts with EED and EZH2; the interactions are indicative for an association with the PRC2/EED-EZH2 complex. Interacts with SFMBT2. Found in a complex with SMAD1 and SMAD4. Found in a complex with YY1, SIN3A and HDAC1 (By similarity).
Belongs to the YY transcription factor family.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.